glp 1 receptor agonists in idiopathic intracranial hypertension Novel use of GLP-1 agonist therapy for pediatric hypertension: a case report Large-Scale Study Highlights Therapeutic Benefits
Description
doi: 10.1007/s11011-021-00879-1 [DOI] [PubMed] [Google Scholar] 97
Br J Dermatol (2014) 171(1):15561
However, the characteristics of the patients included in the clinical trials give some indication
Yes, mild reductions are often observed
Liraglutide in apoE / mice reduced body weight as well as suppressed macrophage-driven atherosclerosis
[DOI] [PubMed] [Google Scholar] 105
